FdaApplication
NDA 205054
Identifiers
- fda_app_no: NDA205054
Properties
| Property | Value |
|---|---|
| applicant_name | INVAGEN PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2018-08-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEUPROLIDE ACETATE FOR DEPOT SUSPENSION | LEUPROLIDE ACETATE | 22.5MG/VIAL | FOR SUSPENSION;INTRAMUSCULAR |
1 product